Literature DB >> 20171524

Radiation-associated liver injury.

Charlie C Pan1, Brian D Kavanagh, Laura A Dawson, X Allen Li, Shiva K Das, Moyed Miften, Randall K Ten Haken.   

Abstract

The liver is a critically important organ that has numerous functions including the production of bile, metabolism of ingested nutrients, elimination of many waste products, glycogen storage, and plasma protein synthesis. The liver is often incidentally irradiated during radiation therapy (RT) for tumors in the upper- abdomen, right lower lung, distal esophagus, or during whole abdomen or whole body RT. This article describes the endpoints, time-course, and dose-volume effect of radiation on the liver. Published by Elsevier Inc.

Entities:  

Mesh：

Year:  2010        PMID： 20171524      PMCID： PMC4388033          DOI： 10.1016/j.ijrobp.2009.06.092

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


  40 in total

1.  Clinical results and prognostic factors in radiotherapy for unresectable hepatocellular carcinoma: a retrospective study of 158 patients.

Authors:  Jinsil Seong; Hee Chul Park; Kwang Hyub Han; Chae Yoon Chon
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-02-01       Impact factor: 7.038

Review 2.  Partial volume tolerance of the liver to radiation.

Authors:  Laura A Dawson; Randall K Ten Haken
Journal:  Semin Radiat Oncol       Date:  2005-10       Impact factor: 5.934

3.  Inclusion of organ deformation in dose calculations.

Authors:  K K Brock; D L McShan; R K Ten Haken; S J Hollister; L A Dawson; J M Balter
Journal:  Med Phys       Date:  2003-03       Impact factor: 4.071

4.  Extrahepatic portal vein occlusion without recurrence after pancreaticoduodenectomy and intraoperative radiation therapy.

Authors:  Shuichi Mitsunaga; Taira Kinoshita; Mitsuhiko Kawashima; Masaru Konishi; Toshio Nakagohri; Shinichiro Takahashi; Naoto Gotohda
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-10-26       Impact factor: 7.038

5.  Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase i-ii study.

Authors:  Alejandra Méndez Romero; Wouter Wunderink; Shahid M Hussain; Jacco A De Pooter; Ben J M Heijmen; Peter C J M Nowak; Joost J Nuyttens; Rene P Brandwijk; Cees Verhoef; Jan N M Ijzermans; Peter C Levendag
Journal:  Acta Oncol       Date:  2006       Impact factor: 4.089

6.  Accelerated fractionation radiation therapy for liver metastases: selection of an optimal patient population for the evaluation of late hepatic injury in RTOG studies.

Authors:  S A Leibel; C Guse; S E Order; F R Hendrickson; R U Komaki; C H Chang; L W Brady; T H Wasserman; K J Russell; S O Asbell
Journal:  Int J Radiat Oncol Biol Phys       Date:  1990-03       Impact factor: 7.038

7.  Prediction of radiation-induced liver disease by Lyman normal-tissue complication probability model in three-dimensional conformal radiation therapy for primary liver carcinoma.

Authors:  Zhi-Yong Xu; Shi-Xiong Liang; Ji Zhu; Xiao-Dong Zhu; Jian-Dong Zhao; Hai-Jie Lu; Yun-Li Yang; Long Chen; An-Yu Wang; Xiao-Long Fu; Guo-Liang Jiang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-03-20       Impact factor: 7.038

8.  Image-guided radiotherapy for liver cancer using respiratory-correlated computed tomography and cone-beam computed tomography.

Authors:  Matthias Guckenberger; Reinhart A Sweeney; Juergen Wilbert; Thomas Krieger; Anne Richter; Kurt Baier; Gerd Mueller; Otto Sauer; Michael Flentje
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-05-01       Impact factor: 7.038

9.  Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma.

Authors:  Regina V Tse; Maria Hawkins; Gina Lockwood; John J Kim; Bernard Cummings; Jennifer Knox; Morris Sherman; Laura A Dawson
Journal:  J Clin Oncol       Date:  2008-01-02       Impact factor: 44.544

10.  Hepatitis B virus reactivation after three-dimensional conformal radiotherapy in patients with hepatitis B virus-related hepatocellular carcinoma.

Authors:  Ji Hoon Kim; Joong-Won Park; Tae Hyun Kim; Dong Wook Koh; Woo Jin Lee; Chang-Min Kim
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-05-24       Impact factor: 7.038
View more
  206 in total

Review 1.  Hepatic radiation toxicity: avoidance and amelioration.

Authors:  Chandan Guha; Brian D Kavanagh
Journal:  Semin Radiat Oncol       Date:  2011-10       Impact factor: 5.934

2.  Unresectable Hepatocellular Carcinoma Due to Portal Venous Thrombosis: Focal Stereotactic Body Radiation Therapy Can Promote Resectability.

Authors:  Andrew Y Lee; Tianming Wu; Michael W Vannier; Giuliano Testa; Stanley L Liauw
Journal:  J Gastrointest Cancer       Date:  2012-09

Review 3.  New techniques for assessing response after hypofractionated radiotherapy for lung cancer.

Authors:  Sarah A Mattonen; Kitty Huang; Aaron D Ward; Suresh Senan; David A Palma
Journal:  J Thorac Dis       Date:  2014-04       Impact factor: 2.895

4.  Dosimetric Analysis and Normal-Tissue Complication Probability Modeling of Child-Pugh Score and Albumin-Bilirubin Grade Increase After Hepatic Irradiation.

Authors:  Jennifer Pursley; Issam El Naqa; Nina N Sanford; Bridget Noe; Jennifer Y Wo; Christine E Eyler; Matthew Hwang; Kristy K Brock; Beow Y Yeap; John A Wolfgang; Theodore S Hong; Clemens Grassberger
Journal:  Int J Radiat Oncol Biol Phys       Date:  2020-04-27       Impact factor: 7.038

Review 5.  Proton beam therapy for gastrointestinal cancers: past, present, and future.

Authors:  Shahed N Badiyan; Christopher L Hallemeier; Steven H Lin; Matthew D Hall; Michael D Chuong
Journal:  J Gastrointest Oncol       Date:  2018-10

6.  Proton beam therapy outcomes for localized unresectable hepatocellular carcinoma.

Authors:  Awalpreet S Chadha; Jillian R Gunther; Cheng-En Hsieh; Maureen Aliru; Lakshmi S Mahadevan; Bhanu P Venkatesulu; Christopher H Crane; Prajnan Das; Joseph M Herman; Eugene J Koay; Cullen Taniguchi; Emma B Holliday; Bruce D Minsky; Yelin Suh; Peter Park; Gabriel Sawakuchi; Sam Beddar; Bruno C Odisio; Sanjay Gupta; Evelyne Loyer; Harmeet Kaur; Kanwal Raghav; Milind M Javle; Ahmed O Kaseb; Sunil Krishnan
Journal:  Radiother Oncol       Date:  2019-01-16       Impact factor: 6.280

7.  Pharmacokinetics, microscale distribution, and dosimetry of alpha-emitter-labeled anti-PD-L1 antibodies in an immune competent transgenic breast cancer model.

Authors:  Jessie R Nedrow; Anders Josefsson; Sunju Park; Tom Bäck; Robert F Hobbs; Cory Brayton; Frank Bruchertseifer; Alfred Morgenstern; George Sgouros
Journal:  EJNMMI Res       Date:  2017-07-18       Impact factor: 3.138

8.  Estimating functional liver reserve following hepatic irradiation: adaptive normal tissue response models.

Authors:  Matthew H Stenmark; Yue Cao; Hesheng Wang; Andrew Jackson; Edgar Ben-Josef; Randall K Ten Haken; Theodore S Lawrence; Mary Feng
Journal:  Radiother Oncol       Date:  2014-05-08       Impact factor: 6.280

9.  2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma.

Authors: 
Journal:  Gut Liver       Date:  2015-05-23       Impact factor: 4.519

10.  Repeated SBRT for in- and out-of-field recurrences in the liver.

Authors:  Eleni Gkika; Iosif Strouthos; Simon Kirste; Sonja Adebahr; Michael Schultheiss; Dominik Bettinger; Ralph Fritsch; Volker Brass; Lars Maruschke; Hannes Philipp Neeff; Sven Arke Lang; Ursula Nestle; Anca-Ligia Grosu; Thomas Baptist Brunner
Journal:  Strahlenther Onkol       Date:  2018-10-23       Impact factor: 3.621
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.